LAUSR

MR imaging is a suitable instrument for the detection of incidental radiological findings in patients with early psychosis and guidance of subsequent treatment adjustments. We outline evidence showing the clinical utility of MR imaging to guide treatment selection by identifying radiological abnormalities and predicting clinical outcomes in early-stage psychosis. We argue that MR imaging is an indispensable screening tool to detect gross radiological abnormalities in early psychosis and implementation in routine clinical assessments is warranted. We highlight future key challenges and make pragmatic suggestions to exploit the potential of MR imaging to construct robust prognostic models for personalized early interventions.